Sex Hormone–Dependent Lipid Mediator Formation in Male and Female Mice During Peritonitis

Introduction: Sex differences in inflammation are obvious and contribute to divergences in the incidence and severity of inflammation-related diseases that frequently preponderate in women. Lipid mediators (LMs), mainly produced by lipoxygenase (LOX) and cyclooxygenase (COX) pathways from polyunsatu...

Full description

Bibliographic Details
Main Authors: Bilancia, R. (Author), Borrelli, F. (Author), Ialenti, A. (Author), Jordan, P.M (Author), Meyer, K.P.L (Author), Pace, S. (Author), Rossi, A. (Author), Sautebin, L. (Author), Serhan, C.N (Author), Troisi, F. (Author), Werz, O. (Author)
Format: Article
Language:English
Published: Frontiers Media S.A. 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 04550nam a2200637Ia 4500
001 10-3389-fphar-2021-818544
008 220420s2022 CNT 000 0 und d
020 |a 16639812 (ISSN) 
245 1 0 |a Sex Hormone–Dependent Lipid Mediator Formation in Male and Female Mice During Peritonitis 
260 0 |b Frontiers Media S.A.  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.3389/fphar.2021.818544 
520 3 |a Introduction: Sex differences in inflammation are obvious and contribute to divergences in the incidence and severity of inflammation-related diseases that frequently preponderate in women. Lipid mediators (LMs), mainly produced by lipoxygenase (LOX) and cyclooxygenase (COX) pathways from polyunsaturated fatty acids (PUFAs), regulate all stages of inflammation. Experimental and clinical studies revealed sex divergences for selected LM pathways without covering the entire LM spectrum, and only few studies have addressed the respective role of sex hormones. Here, we performed the comprehensive LM profile analysis with inflammatory peritoneal exudates and plasma from male and female mice in zymosan-induced peritonitis to identify the potential sex differences in LM biosynthesis during the inflammatory response. We also addressed the impact of sex hormones by employing gonadectomy. Methods: Adult male and female CD1 mice received intraperitoneal injection of zymosan to induce peritonitis, a well-established experimental model of acute, self-resolving inflammation. Mice were gonadectomized 5 weeks prior to peritonitis induction. Peritoneal exudates and plasma were taken at 4 (peak of inflammation) and 24 h (onset of resolution) post zymosan and subjected to UPLC–MS-MS–based LM signature profiling; exudates were analyzed for LM biosynthetic proteins by Western blot; and plasma was analyzed for cytokines by ELISA. Results: Pro-inflammatory COX and 5-LOX products predominated in the peritoneum of males at 4 and 24 h post-zymosan, respectively, with slightly higher 12/15-LOX products in males after 24 h. Amounts of COX-2, 5-LOX/FLAP, and 15-LOX-1 were similar in exudates of males and females. In plasma of males, only moderate elevation of these LMs was apparent. At 4 h post-zymosan, gonadectomy strongly elevated 12/15-LOX products in the exudates of males, while in females, free PUFA and LOX products were rather impaired. In plasma, gonadectomy impaired most LMs in both sexes at 4 h with rather up-regulatory effects at 24 h. Finally, elevated 15-LOX-1 protein was evident in exudates of males at 24 h which was impaired by orchiectomy without the striking impact of gonadectomy on other enzymes in both sexes. Conclusions: Our results reveal obvious sex differences and roles of sex hormones in LM biosynthetic networks in acute self-resolving inflammation in mice, with several preponderances in males that appear under the control of androgens. Copyright © 2022 Troisi, Pace, Jordan, Meyer, Bilancia, Ialenti, Borrelli, Rossi, Sautebin, Serhan and Werz. 
650 0 4 |a adult 
650 0 4 |a animal experiment 
650 0 4 |a animal model 
650 0 4 |a arachidonate 12 lipoxygenase 
650 0 4 |a arachidonate 15 lipoxygenase 
650 0 4 |a arachidonate 5 lipoxygenase 
650 0 4 |a arachidonate 5 lipoxygenase activating protein 
650 0 4 |a Article 
650 0 4 |a controlled study 
650 0 4 |a cyclooxygenase 2 
650 0 4 |a enzyme linked immunosorbent assay 
650 0 4 |a female 
650 0 4 |a inflammation 
650 0 4 |a interleukin 1beta 
650 0 4 |a interleukin 6 
650 0 4 |a lipid mediator 
650 0 4 |a lipoxygenase 
650 0 4 |a lipoxygenase 
650 0 4 |a liquid chromatography-mass spectrometry 
650 0 4 |a male 
650 0 4 |a mouse 
650 0 4 |a nonhuman 
650 0 4 |a peritoneum exudate 
650 0 4 |a peritonitis 
650 0 4 |a polyunsaturated fatty acid 
650 0 4 |a prostaglandin synthase 
650 0 4 |a sex difference 
650 0 4 |a sex differences 
650 0 4 |a sex hormone 
650 0 4 |a specialized pro-resolving mediators 
650 0 4 |a Western blotting 
650 0 4 |a zymosan-induced peritonitis 
700 1 0 |a Bilancia, R.  |e author 
700 1 0 |a Borrelli, F.  |e author 
700 1 0 |a Ialenti, A.  |e author 
700 1 0 |a Jordan, P.M.  |e author 
700 1 0 |a Meyer, K.P.L.  |e author 
700 1 0 |a Pace, S.  |e author 
700 1 0 |a Rossi, A.  |e author 
700 1 0 |a Sautebin, L.  |e author 
700 1 0 |a Serhan, C.N.  |e author 
700 1 0 |a Troisi, F.  |e author 
700 1 0 |a Werz, O.  |e author 
773 |t Frontiers in Pharmacology